MS experts analyse whether the COVID-19 vaccine causes demyelination; BCG vaccine for tuberculosis not linked to MS risk; and a study on cognition & motor performance in relapsing-remitting MS offers new insights.
These noteworthy MS news highlights and more are included in our recently published ECTRIMS Bulletins – a 30-day snapshot of global news & publications on MS research, treatment and care.
> Read the full Bulletin here.
ECTRIMS Bulletins can be sent to you every month, delivered straight to your inbox, via our free subscription service. Simply select all “topics” that are of interest to you, and when one of those appears in our news & publication cycle you’ll be sure to hear from us.